3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Pancreatic Neoplasms
6
Prostatic Neoplasms
4
Nasopharyngeal Carcinoma
4
Carcinoma, Hepatocellular
4
Sarcoma
2
Radiation Injuries
2
Melanoma
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Rectal Neoplasms
1
Pancreatic Cancer Non-resectable
1
Ovarian Neoplasms
1
Osteosarcoma
1
Meningioma
1
Locally Advanced Pancreatic Cancer
1
Glioma
1
Chondrosarcoma
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
Doxorubicin
141
Ifosfamide
85
Radiotherapy
80
Cyclophosphamide
72
Gemcitabine
63
Filgrastim
54
pembrolizumab
43
pazopanib
39
Etoposide
39
Docetaxel
39
Vincristine
37
Cisplatin
35
Trabectedin
32
Nivolumab
32
Irinotecan
26
Magnetic Resonance Spectroscopy
25
Carboplatin
25
Temozolomide
23
Ipilimumab
22
Bevacizumab
20
Radiation
19
Granulocyte Colony-Stimulating Factor
18
Surgical Procedures, Operative
17
Sirolimus
17
Mesna
17
Melphalan
17
Dactinomycin
17
Biopsy
17
eribulin
16
Specimen Handling
16
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Sarcoma
×
Heavy Ion Radiotherapy
×
Clear all
NCT04219202
2026-03-10
Retro-Ion
University Hospital Heidelberg
Phase NA
Recruiting
64 enrolled
NCT07250334
2025-11-26
SARCOMA-01
Yonsei University
Phase NA
Not yet recruiting
60 enrolled